在抗瘤治疗中编程细胞死亡研究的进展:全面的概述
Shuxin Wei1,2, Chuangye Han3,2, Shutian Mo3
1School of Basic Medical Sciences, Guangxi Medical University, Nanning, 530021, China.
Apoptosis : an international journal on programmed cell death
|November 2, 2024
概括
编程细胞死亡 (PCD) 途径调节正常细胞死亡,对于抑制瘤生长至关重要. 本综述探讨了PCD机制及其在新型抗瘤治疗策略中的应用.
科学领域:
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 细胞死亡是一种基本的生理过程,涉及多种途径,包括DNA损伤,细胞循环停止和编程细胞死亡 (PCD).
- 编程细胞死亡 (PCD) 是瘤学研究的一个关键领域,有各种类型,如亡,自,亡,热亡,铁亡和脱硫亡.
- PCD在维持组织平衡和抑制瘤发生和发展方面发挥着至关重要的作用.
研究的目的:
- 系统地审查编程细胞死亡 (PCD) 的调节机制.
- 总结基于PCD的抗瘤治疗策略的最新研究进展.
主要方法:
- 基础和临床研究的系统文献综述.
- 对不同类型的PCD监管机制的分析.
- 汇编了关于基于PCD的抗瘤疗法的当前研究.
主要成果:
- 详细概述了管理PCD的各种监管途径.
- 确定与癌症研究相关的关键PCD类型.
- 新兴的抗瘤策略利用PCD的总结.
结论:
- 编程细胞死亡 (PCD) 对开发创新的抗瘤疗法具有重大潜力.
- 了解PCD机制对于推进癌症治疗策略至关重要.
更多相关视频
10:03Author Spotlight: Understanding Cytokine-Induced Cell Death in Intestinal Epithelial Cells Using Human Organoids
Published on: August 2, 2024
1.3K
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
484
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
